Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
115 hedge funds and large institutions have $595M invested in Axonics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 18 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
184% more call options, than puts
Call options by funds: $7.91M | Put options by funds: $2.79M
83% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 18
32% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 28
12% more funds holding
Funds holding: 103 → 115 (+12)
5% more capital invested
Capital invested by funds: $565M → $595M (+$30.3M)
Top Buyers
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$36.5M |
| 2 |
DM
Deerfield Management
New York
|
+$28.4M |
| 3 |
Axa
Paris,
France
|
+$27.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.1M |
Top Sellers
AXNX Hedge Fund Activity: Q1 2020 in Review
115 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2020, worth a combined $595M — up 5.4% from $565M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new AXNX positions and 18 closed out — a net gain of 15 holders — while 37 added to existing stakes and 28 trimmed.
The largest buyer was Polar Capital, opening a new position worth an estimated $36.5M. The largest seller was Millennium Management, cutting an estimated $40.9M.
- 115 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2020, up from 103 in Q4 2019.
- Funds reported $595M of Axonics, Inc. Common Stock stock for Q1 2020, up 5.4% quarter-over-quarter.
- 33 funds opened new Axonics, Inc. Common Stock positions in Q1 2020 and 18 closed out, a net change of +15 holders.
- The largest Axonics, Inc. Common Stock buyer in Q1 2020 was Polar Capital, an estimated $36.5M added.
- The largest Axonics, Inc. Common Stock seller in Q1 2020 was Millennium Management, an estimated $40.9M sold.
Based on aggregated 13F filings for Q1 2020.